Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024 (Marina Temkin/TechCrunch)
Triomics raised $22 million to expand its oncology-focused AI platform for automating data-heavy clinical tasks.
Excerpt
<a href="https://techcrunch.com/2026/05/27/triomics-nabs-22m-to-bring-oncology-specific-ai-to-cancer-centers/"><img align="RIGHT" border="0" hspace="4" src="http://www.techmeme.com/260528/i64.jpg" vspace="4" /></a>
<p><a href="https://www.techmeme.com/260528/p64#a260528p64" title="Techmeme permalink"><img height="12" src="http://www.techmeme.com/img/pml.png" style="border: none; padding: 0; margin: 0;" width="11" /></a> Marina Temkin / <a href="http://techcrunch.com/">TechCrunch</a>:<br />
<span style="font-size: 1.3em;"><b><a href="https://techcrunch.com/2026/05/27/triomics-nabs-22m-to-bring-oncology-specific-ai-to-cancer-centers/">Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024</a></b></span> — Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks … </p>
Read at source: https://www.techmeme.com/260528/p64#a260528p64